• OPEN AN ACCOUNT
Indian Indices
Nifty
25,145.50 -81.85
(-0.32%)
Sensex
82,029.98 -297.07
( -0.36%)
Bank Nifty
56,496.45 -128.55
( -0.23%)
Nifty IT
35,214.85 -115.95
( -0.33%)
Global Indices
Nasdaq
46,089.04 588.43
(1.29%)
Dow Jones
6,674.95 101.44
(1.54%)
Hang Seng
46,768.58 -1,320.22
(-2.75%)
Nikkei 225
9,442.87 15.40
(0.16%)
Forex
USD-INR
88.75 -0.06
(-0.07%)
EUR-INR
103.09 0.08
(0.07%)
GBP-INR
118.50 -0.08
(-0.06%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
290.1676063
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
32.28
30206.31
EPS(TTM)
Face Value()
Div & Yield %
74.9
2
1.16
 

Baid Finserv Ltd - Intimation Regarding Postponement Of The Rights Issue Committee Meeting To Be Held On September 15 2025 For Deciding Issue Price And Other Terms Of The Rights Issue.
Sep 15,2025
In furtherance to our earlier intimation dated September 11 2025 this is to inform you that the meeting of the Rights Issue Committee of the Board of Directors of the Company was scheduled to be held Today at 04:00 P.M. to consider and approve the terms and conditions of the Rights Issue. As the approval from BSE Limited and National Stock Exchange w.r.t above said Rights Issue is under process. In view of the same the revised date for the meeting of the Rights Issue committee shall be communicated upon receipt of the requisite approvals.